New Clinical Data Shows Significant Delay in Disease Progression and Cognitive Decline in Alzheimer’s Patients Using Cognito’s Wearable Neurotech
New leadership and AI-driven technology aim to revolutionize assessment and care for brain-related conditions
Neurent Medical announced that it received FDA 510(k) clearance for its next-generation Neuromark system for chronic rhinitis.
Accelus today announced it received FDA 510(k) clearance for its FlareHawk Interbody Fusion System to be safely scanned under certain MRI conditions
SARASOTA, Fla. and HUNTSVILLE, Ala., June 11, 2025 /PRNewswire/ — World Precision Instruments (WPI), a global leader in transepithelial electrical resistance (TEER) instrumentation, and SynVivo Inc., a pioneer in Organ-on-a-Chip (OOC) technology, today announced the commercial launch of a next-generation multiplexed TEER-on-a-Chip platform—a breakthrough solution enabling real-time, high-throughput measurement of barrier integrity in advanced Organ-on-a-Chip models.
Researchers from Tel Aviv University and Sheba Tel Hashomer Medical Center have developed an innovative bioengineered skin equivalent for grafting in burn victims. The bioengineered skin produced from the patient’s own cells is more stable, robust, and flexible than current treatments, making it easier to handle.
A medical research team at Saarland University, led by Professor Bergita Ganse, has discovered a new approach to monitoring bone fracture healing by measuring blood supply to the tissue at the fracture site and the level of oxygen in the blood. Bone regeneration can be monitored quickly and easily using near-infrared light rather than harmful shorter wavelength radiation.
Each year, millions of people in the U.S. get dental implants as a long-term, natural-looking fix for missing teeth. But traditional implants don’t fully mimic real teeth.
Researchers at the University of California, Davis, have developed an investigational brain-computer interface that holds promise for restoring the voices of people who have lost the ability to speak due to neurological conditions.
First-in-class gene therapy moves toward clinical trials to address a life-threatening genetic heart condition with high unmet need